Results for this period
Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue increased due to price revisions in response to higher raw material prices, including naphtha, and foreign exchange differences. Core operating profit increased due to improved inventory valuation gains and losses and improved terms of trade resulting from price revisions. At the segment level, the factors cited include the consolidation of Ultradent as a subsidiary, the benefits of integrating the domestic polyolefin business, business structure improvements, and improved terms of trade resulting from higher raw material prices.
No applicable items
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 September 2026 |
| Net Sales | ¥979,082 million (YoY +20.3%) |
| Operating profit | ¥93,764 million (YoY +235.6%) |
| Ordinary income | 90,581 Millions of yen (interim profit before tax) (YoY +246.2%) |
| Profit attributable to owners of the parent | ¥58,822 million (YoY +650.0%) |
| Net income per share | ¥162.71 |
| Equity ratio | End of the current fiscal period 35.9% / End of previous period 40.2% |
| Total assets | ¥2,476,740 million |
| Net assets | ¥1,041,621 million (total equity) |
| Cash flows from operating activities | ¥91,087 million |
| Cash flows from investing activities | ¥-181,174 million |
| Cash flows from financing activities | ¥114,159 million |
| Cash and cash equivalents at end of period | ¥205,131 million |
| Full-year earnings forecast | Net Sales ¥2,095,000 million (YoY +25.5%) / Core operating profit ¥150,000 million (YoY +50.0%) / Operating profit ¥112,000 million (YoY +51.7%) / Ordinary income ¥101,000 million (profit before tax) / Profit for the period ¥70,000 million (YoY +49.2%) / Profit for the year attributable to owners of the parent ¥53,000 million (YoY +54.2%) |
| Revision to Earnings Forecast | Revenue ¥19,000 billion → ¥20,950 billion(+10.3%) / Core operating profit ¥1,050 billion → ¥1,500 billion(+42.9%) / Operating profit ¥830 billion → ¥1,120 billion(+34.9%) / Profit for the period ¥550 billion → ¥700 billion(+27.3%) / Profit for the year attributable to owners of the parent ¥450 billion → ¥530 billion(+17.8%) |
| Annual Dividend Forecast | ¥75 per share (adjusted for the stock split) → ¥75 per share (adjusted for the stock split)(0.0%) |
| Segment revenue | Life & Healthcare Solutions ¥134,564 million, Mobility Solutions ¥300,424 million, ICT Solutions ¥159,258 million, Basic & Green Materials ¥376,486 million, Other ¥8,350 million |
| Segment profit | Life & Healthcare Solutions ¥12,742 million (core operating profit), Mobility Solutions ¥36,545 million (core operating profit), ICT Solutions ¥24,787 million (core operating profit), Basic & Green Materials ¥28,238 million (core operating profit), Other ¥258 million (core operating profit) |
| Depreciation and amortization | ¥58,706 million (depreciation and amortization) |
| Impairment loss | ¥1,399 million. Asset subject to impairment: Not disclosed |
| Disclosure regarding the going concern assumption | No applicable items |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 21 / Company name MC Dental Holdings America, Inc., Ultradent Products, Inc. and 19 subsidiaries / Excluded Number of companies 0 / Company name No |
| Material subsequent events | A share transfer agreement for JSR Corporation was signed, and the transaction to make JSR Corporation a consolidated subsidiary was approved on 9 November 2026. The acquisition price is expected to be ¥1.84 trillion, with completion targeted for the second half of fiscal 2027. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for institutional investors and analysts) |
| Issued Shares at Period-End | 381,587,374 shares |
| Treasury Shares at Period-End | 20,060,171 shares |
| Factors Behind Changes in Business Performance | Revenue increased due to price revisions in response to higher raw material prices, including naphtha, and foreign exchange differences. Core operating profit increased due to improved inventory valuation gains and losses and improved terms of trade resulting from price revisions. At the segment level, the factors cited include the consolidation of Ultradent as a subsidiary, the benefits of integrating the domestic polyolefin business, business structure improvements, and improved terms of trade resulting from higher raw material prices. |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue and each profit measure are expected to exceed the previously announced forecasts, due to improved terms of trade resulting from price revisions in response to higher raw material prices, including naphtha, improved inventory valuation gains and losses, foreign exchange differences and other factors.